Solifenacin Stada is used to treat symptoms of overactive bladder syndrome.
The active substance is solifenacin succinate.
Each film-coated tablet contains 5 mg of solifenacin succinate, equivalent to 3.8 mg of solifenacin.
This medicine is used to reduce the activity of an overactive bladder.
It provides more time before needing to go to the toilet and increases the bladder's capacity to hold urine.
Solifenacin STADA is used to treat symptoms of overactive bladder syndrome, which include:
A sudden and urgent need to urinate without warning,
Frequent urination,
Involuntary leakage of urine (urge incontinence) due to not reaching the toilet in time.
Always follow your doctor’s instructions on how to use this medication.
If you are unsure, consult your doctor or pharmacist again.
Dosage:
The recommended dose is 5 mg once daily, unless your doctor advises you to take 10 mg once daily.
Method of Administration:
Swallow the tablet whole with some liquid (e.g., a glass of water).
You may take the tablet with or without food, as preferred.
Do not crush or chew the tablet.
Use in Children and Adolescents:
Solifenacin should not be used in children or adolescents under 18 years of age.
Do not use solifenacin if you are pregnant, unless absolutely necessary.
Do not use this medicine while breastfeeding, as solifenacin may pass into breast milk.
If you are pregnant, breastfeeding, think you may be pregnant, or are planning to have a baby, consult your doctor or pharmacist before taking this medicine.
Solifenacin STADA may cause blurred vision, and sometimes drowsiness or fatigue.
If you experience any of these effects, do not drive or operate machinery.
This medicine does not require any special temperature storage conditions.
Store in the original package to protect from moisture.
Keep out of the reach of children.
